BiotechExec provides executive search and management consulting services specifically for the biotech and medtech sectors.

BiotechExec

Synovivo is involved in the recruitment of executives and experts in the agricultural and agro-industrial sectors. The company focuses on optimizing HR decisions and providing operational consulting.

Synovivo

BiotechExec | 1,022 followers on LinkedIn. Fractional CXO&#39;s, advisory, consulting, and executive search for growing medtech and biotech companies. | Executives for medical device, biotech, diagnostics and digital health companies. Providing fractional, interim and full-time experienced C-suite executives to help grow life science businesses. Our advisory and consulting services are also available to assist companies with their commercialization strategies, business development and product development needs.

CEO @ Southern Metrics | Musculoskeletal Results

Chris Lyons

President & CEO, Syncromune, Inc,

Eamonn Hobbs

Experienced executive leader proficient in Commercial Operations. Passionate and driven to exceed customer expectations in the healthcare, life…

Kent Rarick

BiotechExec, Senior Account Executive | Driving Growth for Life Science Companies

Kathi Farris

Well said Kent ! The key word here being "curated." Fractional roles and consulting is not for everyone, and our placements are not just stop-overs for those seeking full-time employment elsewhere. We place committed leaders who are willing to work with our clients in this consulting capacity often with the intent to stay long term and convert to employment after a trial period of a few months. I like the term "agile leadership!"

Russell Allen

In the dynamic healthcare and life sciences startup landscape, fractional CxO roles are gaining momentum as a strategic career choice. These executive positions offer leaders the chance to broaden their skills and boost their income while enjoying flexibility and continuous growth opportunities. Healthcare and life science organizations benefit from the ability to tap into virtual resources to access specialized talent on a fractional basis, optimizing costs and efficiency. BiotechExec is a leader in this market, providing healthcare and life science companies with the ability to obtain top-tier expertise precisely when required, driving innovation, adaptability and focus in an ever-evolving industry. Contact me if you would like to learn more! 🚀💉 #FractionalCxO #HealthcareLeadership #LifeSciencesInnovation #AgilityInBusiness #ExecutiveRoles #FutureOfWork #BiotechExec #healthcarestartup #lifesciencestartup

BiotechExec's Russell Allen weighs in on interest rates' impact on life science venture investing.

Thank you Angela Gabriel and your contributors for these insights on the value of fractional leadership in life sciences. In addition to cost savings, I thought I would highlight some other benefits of this evolving model. Indeed, we started BiotechExec to address budget constraints in emerging life science companies. We have since expanded the model by incorporating trial C-suite roles that may later convert to full-time positions, and to consulting projects for companies and their investors led by these operating execs. This allows our clients to not only cut costs through the efficiency of these experienced professionals, but also minimize the risk of committing to full-time employment before both the company and executive have had time to assess their fit with one another. Plus, our nationwide executive presence removes the geographic limitations often faced by companies outside major life science hubs and brings the right domain expertise without compromise. Consulting and fractional work isn’t for everyone—we exclusively accept CEOs and other CXOs into our Ignite Network with the strongest track records of success, referred only by trusted peers, and invest significant effort into onboarding them to ensure they are ideally suited for these roles. We believe this "on demand" executive model is here to stay through both tough and strong investment climates.

Congratulations to BiotechExec Principal, Chris Lyons , and the OrthoGrid team!

Congratulations Bill Martin! We are excited to partner with NanoPharma Solutions and look forward to following your progress.

BiotechExec would like to wish all of our clients, team members and everyone celebrating today, a very happy Fourth of July! We hope everyone has a fantastic celebration. #IndependenceDay #FourthOfJuly #LifeScience #Biotech #Medtech

We are thrilled to announce the launch of our private equity consulting practice, Ignite Health Advisors (IHA). IHA focuses on middle-market life science and healthcare PE-sponsored companies and investments. Chris S. has joined us as Managing Director of IHA, having led multiple assignments with private equity and executive leadership of health and medical technology companies. To learn more, please visit us at https://lnkd.in/erRn-ZsK or reach out to Chris at ignite@biotechexec.com or 404-953-5255.

BiotechExec's Stephen Joseph will be at the 2024 Bio CEO & Investor Conference. Please connect with Steve to learn how our experienced C-level network strengthens executive #teams in #lifesciences . Russell Allen , William Dull , Matthew White, CFA

We would like to highlight one of BiotechExec's premier clients: CytexOrtho . CytexOrtho has received a prestigious win at #aaos2024 . Congrats! To learn more about CytexOrtho, please reach out to Brad Estes, Ph.D. , Chris Lyons , Spencer Jones .

Metric
Company Name	BiotechExec	Synovivo
Symbol
MSH ID	COM:BIOTECHEXEC	COM:SYNOVIVO
Market	PRIVATE	PRIVATE
Sector	Commercial & Professional Services	Commercial & Professional Services
Industry	Consulting	Recruitment and Consulting
Country	US	FR
Stage
Employee Count
Website	biotechexec.com	synovivo.com
LinkedIn	biotechexec	synovivo-recrutement
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIOT

COM:BIOTECHEXEC

BiotechExec

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue